Open randomised prospective comparative multi-centre intervention study of patients with Cystic fibrosis and early diagnosed diabetes mellitus

BMC Pediatrics

Volumn 14, Issue 1, 2014, Pages

  Ballmann, Manfred ^a   Hubert, Dominique ^b   Assael, Barouk M ^c   Kronfeld, Kai ^d   Honer, Marguerite ^e   Holl, Reinhard W ^f   Staden, U ^g   Classen M ^h   Schuster, A ⁱ   Mellies, U ^j   Posselt, H G ^k   Ballmann, M ^l   Wiebel, M ^m   Rietschel, E ⁿ   Stern, M ^o   Teschler, H ^p   Smaczny, C ^q   Kohnlein T ^l   Wienhausen Wilke, V ^r   Claass A ^s   Biedermann, T ^t   Nahrlich L ^u   Dockter, G ^v   Koster H ^w   Hebestreit, A ^x   Balke, E H ^y   Heuer, H E ^z   Kamin, W ^d   Kuster P ^aa   Szczepanski, R ^ab   Keller, K M ^ac   Generlich, H ^t   Bresser, H G ^ad   Kopp, M ^ae   Herting, E ^af   Kreger, K ^ag   Feikert, H J ^ah   Hautz, J ^ai   Schilling, B ^aj   Meyer, E ^ak   Mall, M ^al   Wiebicke, W ^am   Tegtmeye, F K ^an   Assael, B ^c   Hubert, D ^b   Mosnier Pudar, H ^b   Lenoir, G ^ao   Robert, Jean Jacques ^ao   Kessler, L ^ap   Weiss, L ^aq   Nove Josserand, R ^ar   Vantygehm, M C ^as   Munck, A ^at   Wizla, N ^au   Leroy, S ^au   Loeuille, G A ^av   Thalhammer, D ^aw   Huttegger, I ^ax   Eichler, I ^ay   Gotz M ^az   more..

^a ST JOSEF HOSPITAL   (Germany)

^b Service de Pneumologie APHP Hôpital Cochin ^*  (France)

^c UNIVERSITY HOSPITAL OF VERONA   (Italy)

^d UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^e Mukoviszidose Institut gGmbH   (Germany)

^f UNIVERSITY OF ULM   (Germany)

^g Zentralklinik Emil von Behring   (Germany)

^h Zentralkrankenhaus Links der Weser   (Germany)

ⁱ Universitätskinderklinik Ambulanz II   (Germany)

^j UNIVERSITY HOSPITAL ESSEN   (Germany)

^k Frankfurt Main Zentrum der Kinderheilkunde Abt Allgemeine Pädiatrie I   (Germany)

^l HANNOVER MEDICAL SCHOOL   (Germany)

^m Thoraxklinik gGmbH   (Germany)

ⁿ UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^o UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^p RUHRLANDKLINIK   (Germany)

^q Med Klinik II Schwerpunkt Pneumologie/Allergologie   (Germany)

^r Klinik Schillerhohe   (Germany)

^s Städt Krankenhaus Klinik f Kinder und Jugendmedizin   (Germany)

^t Deutsche Akademie fur Kinder und Jugendmedizin e V   (Germany)

^u UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^v SAARLAND UNIVERSITY   (Germany)

^w Kinderklinik Oldenburg   (Germany)

^x UNIVERSITY OF WÜRZBURG   (Germany)

^y UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^z Department of Neurosurgery   (Germany)

^aa Clemenshospital Munster   (Germany)

^ab Kinderhospital Osnabruck   (Germany)

^ac DKD Wiesbaden   (Germany)

^ad Kinderzentrum der Krankenanstalten Gilead Päd Pneumologie   (Germany)

^ae UNIVERSITY OF FREIBURG   (Germany)

^af UNIVERSITY OF GÖTTINGEN   (Germany)

^ag MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^ah Klinikum Neubrandenburg   (Germany)

^ai Offenburg University   (Germany)

^aj Kinderklinik Dritter Orden   (Germany)

^ak Reinhard Nieter Krankenhaus Stadtische Kliniken gGmbH   (Germany)

^al UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^am Hesskinderklinik   (Germany)

^an Kinderkrankenhaus Park Schonfeld   (Germany)

^ao HÔPITAL NECKER ENFANTS MALADES   (France)

^ap UNIVERSITÉ DE STRASBOURG   (France)

^aq HÔPITAL DE HAUTEPIERRE   (France)

^ar CENTRE HOSPITALIER LYON SUD   (France)

^as LILLE UNIVERSITY HOSPITAL   (France)

^at HÔPITAL ROBERT DEBRÉ   (France)

^au Cystic Fibrosis Centre   (France)

^av Centre Hospitalier de Dunkerque   (France)

^aw Univ Kiln Kinder Jungendheilkunde   (Austria)

^ax St Johanns Spital   (Austria)

^ay UNIV KLIN KINDER JUGENDHEILKUNDE   (Austria)

^az WILHELMINEN HOSPITAL   (Austria)

more..

Author keywords

Clinical trial; Cystic fibrosis; Diabetes mellitus; Genetic diseases; HbA1c; Inborn; Insulin; Lung diseases; Repaglinide

Indexed keywords

BIGUANIDE DERIVATIVE; GLIBENCLAMIDE; GLUCOSE; GLYCOSIDASE INHIBITOR; HEMOGLOBIN A1C; INSULIN SENSITIZING AGENT; ISOPHANE INSULIN; PIG INSULIN; REPAGLINIDE;

ADOLESCENT; ARTICLE; BODY MASS; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; FORCED EXPIRATORY VOLUME; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTRANSAMINASEMIA; HYPOGLYCEMIA; INSULIN TREATMENT; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OPEN STUDY; ORAL GLUCOSE TOLERANCE TEST; PREDICTIVE VALUE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SCREENING TEST; TREATMENT DURATION; WORLD HEALTH ORGANIZATION; Z SCORE;

ADOLESCENT; ALGORITHMS; CARBAMATES; CHILD; CYSTIC FIBROSIS; DIABETES MELLITUS; EARLY DIAGNOSIS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; PIPERIDINES; PROSPECTIVE STUDIES;

EID: 84897474332     PISSN: None     EISSN: 14712431     Source Type: Journal    
DOI: 10.1186/1471-2431-14-70     Document Type: Article

References (14)

1. Kelly A, Moran A. Update on Cystic fibrosis-related diabetes. J Cyst Fibros 2013, 12(4):318-331. 10.1016/j.jcf.2013.02.008, 23562217.
2. Moran A, Brunzell C, Cohen RC, Katz M, Marshall BC, Onady G, Robinson KA, Sabadosa KA, Stecenko A, Slovis B. Clinical care guidelines for Cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society. Diabetes Care 2010, 33(12):2697-2708. 10.2337/dc10-1768, 2992215, 21115772.
3. Onady GM, Stolfi A. Insulin and oral agents for managing Cystic fibrosis-related diabetes. Cochrane Database Syst Rev 2013, 7. CD004730.
4. Fischman D, Nookala VK. Cystic fibrosis-related diabetes mellitus: etiology, evaluation, and management. Endocr Pract 2008, 14(9):1169-1179. 10.4158/EP.14.9.1169, 19158056.
5. Onady GM, Stolfi A. Insulin and oral agents for managing Cystic fibrosis-related diabetes. Cochrane Database Syst Rev 2005, 3. CD004730.
6. Mueller-Brandes C, Holl RW, Nastoll M, Ballmann M. New criteria for impaired fasting glucose and screening for diabetes in Cystic fibrosis. Eur Respir J 2005, 25(4):715-717. 10.1183/09031936.05.00068104, 15802348.
7. Rosenecker J, Eichler I, Barmeier H, von der Hardt H. Diabetes mellitus and Cystic fibrosis: comparison of clinical parameters in patients treated with insulin versus oral glucose-lowering agents. Pediatr Pulmonol 2001, 32(5):351-355. 10.1002/ppul.1143, 11596159.
8. Onady GM, Langdon LJ. Insulin versus oral agents in the management of Cystic Fibrosis Related Diabetes: a case based study. BMC Endocr Disord 2006, 6:4. 10.1186/1472-6823-6-4, 1513574, 16790062.
9. Moran A, Pekow P, Grover P, Zorn M, Slovis B, Pilewski J, Tullis E, Liou TG, Allen H. Insulin therapy to improve BMI in Cystic fibrosis-related diabetes without fasting hyperglycemia: results of the Cystic fibrosis related diabetes therapy trial. Diabetes Care 2009, 32(10):1783-1788. 10.2337/dc09-0585, 2752940, 19592632.
10. Bretzel RG. Diagnostik und Therapie. Diabetologie in Klinik und Praxis 2011, 192-211. Stuttgart, New York: Thieme, Haering HU, Gallwitz B, Mueller-Wieland D, Usadel K-H, Mehnert H, 6.
11. Lanng S, Hansen A, Thorsteinsson B, Nerup J, Koch C. Glucose tolerance in patients with Cystic fibrosis: five year prospective study. Bmj 1995, 311(7006):655-659. 10.1136/bmj.311.7006.655, 2551427, 7549632.
12. Ziaian T, Sawyer MG, Reynolds KE, Carbone JA, Clark JJ, Baghurst PA, Couper JJ, Kennedy D, Martin AJ, Staugas RE, French DJ. Treatment burden and health-related quality of life of children with diabetes, Cystic fibrosis and asthma. J Paediatr Child Health 2006, 42(10):596-600. 10.1111/j.1440-1754.2006.00943.x, 16972965.
13. Sawicki GS, Sellers DE, Robinson WM. High treatment burden in adults with Cystic fibrosis: challenges to disease self-management. J Cyst Fibros 2009, 8(2):91-96. 10.1016/j.jcf.2008.09.007, 2680350, 18952504.
14. Schmid K, Fink K, Holl RW, Hebestreit H, Ballmann M. Predictors for future Cystic fibrosis-related diabetes by oral glucose tolerance test. J Cyst Fibros 2014, 13(1):80-85. 10.1016/j.jcf.2013.06.001, 23809507.